Pharmaceutical
ChemLinkedMarketChemicalFoodCosmeticPharmaceuticalJapanAgrochemicalSustainability
News
Comprehensive coverage on the latest pharmaceutical regulatory update and industry activities in China.
INDUSTRY
Innovative Drug Biological Product Biosimilar New Drug China
Monthly Report: New Drug Approvals in China | August 2024 In August 2024, China NMPA approved 17 new drugs, among which 7 are chemical drugs and 10 are biological products.
Sep 15, 2024
INDUSTRY
Priority Review Innovative Drug Generic Drug Biosimilar New Drug China
Monthly Report: New Drug Approvals in China | July 2024 In July 2024, China NMPA approved 20 new drugs, among which 15 are chemical drugs and 5 are biological products.
Aug 13, 2024
INDUSTRY
Innovative Drug Generic Drug Biological Product New Drug
Monthly Report: New Drug Approvals in China | June 2024 In June 2024, China NMPA approved 59 new drugs, among which 47 are chemical drugs and 12 are biological products.
Jul 31, 2024
INDUSTRY
Innovative Drug Generic Drug Biological Product Drug Registration New Drug Pediatric Drug
Monthly Report: New Drug Approvals in China | May 2024 In May 2024, China NMPA approved 24 new drugs, among which 19 are chemical drugs and 5 are biological products.
Jun 17, 2024
INDUSTRY
Clinical Trial Innovative Drug New Drug China
China Unveils Data on New Drug Clinical Trial Developments in 2023 China’s Center for Drug Evaluation (CDE) has released its 2023 Annual Report on the Development of New Drug Clinical Trials. The report provided a summary and analysis of the overall landscape of clinical trials, including the total number and basic characteristics of the trials.
May 27, 2024
INDUSTRY
OTC Drug
Drug Sales in China: Public Healthcare Institutions and Retail Pharmacies Generate 1,886.5 Billion Yuan in 2023 In 2023, the combined drug sales of public healthcare institutions and retail pharmacies in China totaled 1,886.5 billion yuan, representing a 5.2% increase compared to the previous year. Notably, public healthcare institutions accounted for 70.7% of the overall sales, with retail pharmacies contributing to the remaining 29.3%.
May 17, 2024
INDUSTRY
Innovative Drug Biological Product OTC Drug Drug Registration New Drug
Monthly Report: New Drug Approvals in China | April 2024 In April 2024, China NMPA approved 27 new drugs, among which 18 are chemical drugs and 9 are biological products.
May 15, 2024
INDUSTRY
Clinical Trial CRO
[Updated] Top 10 CROs With the Highest Revenues in 2023 In 2023, most contract research organizations (CROs) on the top 10 list of the highest revenues experienced modest growth rates of less than 5%. Two CROs—Syneos and Catalent even saw a decline in their revenues. Only Lonza and Samsung Biologics achieved year-on-year growth of over 10%.
Apr 30, 2024
INDUSTRY
Marketing Approval Innovative Drug Generic Drug Biological Product Drug Registration New Drug
Monthly Report: New Drug Approvals in China | March 2024 ​In March 2024, China NMPA approved 7 new drugs, among which 4 are chemical drugs and 3 are biological products.
Apr 08, 2024
INDUSTRY
Marketing Approval Priority Review Innovative Drug Generic Drug Biological Product Drug Registration
Monthly Report: New Drug Approvals in China | February 2024 In February 2024, China NMPA approved 13 new drugs, among which 8 are chemical drugs and 5 are biological products.
Mar 12, 2024
12345 ...8 Next
Most Popular